News Image

Top movers in Wednesday's pre-market session

By Mill Chart

Last update: Apr 17, 2024

The US market session of Wednesday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.

Gainers

TickerChangeComment
INVO89.47%INVO BIOSCIENCE INC's (NASDAQ:INVO) shares rose 89.47% to $1.44 during Wednesday's pre-market session. The stock is trading 25.49% lower than a month ago.
WISA64.59%WISA TECHNOLOGIES INC's (NASDAQ:WISA) stock price increased by 64.59% to $10.04. The upward trend from yesterday's 249.0% gain continues in today's pre-market session, reflecting sustained positive performance for NASDAQ:WISA. A press release (Exploring Stock Surges: Key Insights, Noteworthy BUZZ: KAVL, PRSO, DYAI, WISA, JAGX) was released yesterday.
AGFY56.09%During Wednesday's pre-market session, AGRIFY CORP (NASDAQ:AGFY) experienced a 56.09% increase, with the stock price reaching $0.47. Two days ago the company had a press release: Agrify Corporation Reports Full-Year 2023 Earnings.
EDBL49.45%EDIBLE GARDEN AG INC (NASDAQ:EDBL) rose 49.45% to $6.8 during Wednesday's pre-market session. Despite the -13.33% decrease in share value just yesterday, today's pre-market session for NASDAQ:EDBL demonstrates a notable recovery, instilling renewed confidence. Earlier today the company had a press release: Edible Garden Reports Preliminary First Quarter Year-Over-Year Increase in Produce Revenues of 40%; Cut Herb Revenue Increased More Than 200% for the Same Period.
MAPSW35.7%WM TECHNOLOGY INC-CW24's (NASDAQ:MAPSW) stock price increased by 35.7% to $0.07. Following a -18.4% loss in the previous session, NASDAQ:MAPSW displays significant price volatility in today's pre-market session.
VNDA32.13%VANDA PHARMACEUTICALS INC's (NASDAQ:VNDA) stock price is advancing with 32.13% to a price of $5.35. The stock is trading 36.22% lower than a year ago.
PLCE27.71%CHILDREN'S PLACE INC/THE's (NASDAQ:PLCE) shares surged 27.71% to reach $9.08 during the pre-market session on Wednesday. In the last month the stock lost 45.93%.
GRTX21.24%GALERA THERAPEUTICS INC (NASDAQ:GRTX) rose 21.24% to $0.21 during Wednesday's pre-market session. This is a continuation of yesterday's gain of 11.18%.
GPAK21.01%GAMER PAKISTAN INC's (NASDAQ:GPAK) shares rose 21.01% to $0.34. This is a continuation of yesterday's gain of 11.34%.
IMCC17.99%IM CANNABIS CORP's (NASDAQ:IMCC) shares surged 17.99% to reach $0.61 during the pre-market session on Wednesday. Prices are quite volatile here as yesterday NASDAQ:IMCC closed with a -10.86% loss.

Our premarket gainers page will show you the full list.

Pre-market losers

TickerChangeComment
TMQ-25.83%TRILOGY METALS INC's (NYSEARCA:TMQ) shares fell 25.83% to $0.37.
LGVN-24.93%Despite yesterday's decline, LONGEVERON INC-A (NASDAQ:LGVN) experienced a further 24.93% decrease in share price during Wednesday's pre-market session, reaching $2.65. After a strong performance yesterday with a 20.48% gain, NASDAQ:LGVN shows signs of retracement with a 24.93% decline in today's pre-market session.
HUBC-22.58%The pre-market session on Wednesday witnessed a 22.58% decrease in HUB CYBER SECURITY LTD's (NASDAQ:HUBC) shares, with the stock price falling to $1.44. The stock is trading 82.35% higher than a month ago.
DYNT-18.18%The pre-market session on Wednesday witnessed a 18.18% decrease in DYNATRONICS CORP's (NASDAQ:DYNT) shares, with the stock price falling to $0.45. Yesterday's significant 48.49% gain in NASDAQ:DYNT is met with a 18.18% decline in today's pre-market session, reflecting a shift in market sentiment.
SAGE-18.11%Despite yesterday's decline, SAGE THERAPEUTICS INC (NASDAQ:SAGE) experienced a further 18.11% decrease in share price during Wednesday's pre-market session, reaching $12.8. A press release (Sage Therapeutics Announces Topline Results from Phase 2 PRECEDENT Study of Dalzanemdor (SAGE-718) in the Treatment of Mild Cognitive Impairment in Parkinson’s Disease) was released earlier today.
TPET-18.02%TRIO PETROLEUM CORP's (NYSEARCA:TPET) stock price is declining with 18.02% to a price of $0.4. The downward trend from yesterday's -22.56% drop persisted in today's pre-market session, with another decline of 18.02% for NYSEARCA:TPET.
DFLI-17.79%The pre-market session on Wednesday witnessed a 17.79% decrease in DRAGONFLY ENERGY HOLDINGS CO's (NASDAQ:DFLI) shares, with the stock price falling to $0.51. Following yesterday's gain of 36.51%, NASDAQ:DFLI experiences a 17.79% decrease in today's pre-market session, indicating a pullback from the previous session's performance. A press release (Dragonfly Energy Reports Fourth Quarter 2023 and Full Year Financial Results) was released two days ago.
IZM-15.93%The pre-market session on Wednesday witnessed a 15.93% decrease in ICZOOM GROUP INC -CLASS A's (NASDAQ:IZM) shares, with the stock price falling to $42.89. In the last month the share price increased with 461.0%.
OTRK-15.85%ONTRAK INC's (NASDAQ:OTRK) shares experienced a 15.85% decline, falling to $0.39 during Wednesday's pre-market session. Yesterday the company had a press release: Ontrak Announces 2023 Fourth Quarter and Year End Financial Results.
SPCB-15.8%The pre-market session on Wednesday witnessed a 15.8% decrease in SUPERCOM LTD's (NASDAQ:SPCB) shares, with the stock price falling to $0.31. In the last month the stock gained 129.0%.

Our premarket losers page will show you the full list.

Back

SAGE THERAPEUTICS INC

NASDAQ:SAGE (5/13/2024, 7:00:02 PM)

After market: 12.75 +0.59 (+4.81%)

12.165

+0.26 (+2.23%)

SAGE News

News Image4 days ago - Market News VideoSage Therapeutics Ic Becomes Oversold (SAGE)
News Image7 days ago - Sage TherapeuticsSage Therapeutics to Participate in Upcoming May Investor Conferences
News Image7 days ago - Pomerantz LLPSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Sage Therapeutics, Inc. - SAGE

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Sage Therapeutics, Inc. ("Sage" or the "Company") (NASDAQ: SAGE). Such...

News Image16 days ago - Pomerantz LLPSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Sage Therapeutics, Inc. - SAGE

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Sage Therapeutics, Inc. ("Sage" or the "Company") (NASDAQ: SAGE). Such...

News Image19 days ago - InvestorPlaceSAGE Stock Earnings: Sage Therapeutics Misses EPS, Beats Revenue for Q1 2024

SAGE stock results show that Sage Therapeutics missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.

News Image19 days ago - Sage Therapeutics, Inc.Sage Therapeutics Announces First Quarter 2024 Financial Results and Highlights Pipeline and Business Progress
News Imagea month ago - Yahoo FinanceNeurodegenerative Disorder-Focused Sage Therapeutics Stock Falls On Disappointing Parkinson's Data

Wednesday, Sage Therapeutics Inc (NASDAQ:SAGE) announced topline results from the PRECEDENT Phase 2 study of dalzanemdor (SAGE-718) in people with mild cognitive impairment in Parkinson’s Disease. The PRECEDENT Study did not meet its primary endpoint of demonstrating a statistically significant difference from baseline in participants treated with once-daily dalzanemdor versus placebo on the Wechsler Adult Intelligence Scale Fourth Edition-IV (WAIS-IV) Coding Test score at Day 42. WAIS-IV is the

News Imagea month ago - Investor's Business DailySage Stock Collapses To Record Low After Parkinson's Drug Misses Its Mark

Safe Therapeutics emphasized it's still testing the same drug in patients with Alzheimer's and Huntington's diseases.

SAGE Links
Follow us for more